Požiadavky na publikácie

For Authors

All materials of congress should be edit like papers in a row below and sent to congress committee for approval. Any technical problems or disturbances could be solve in correspondence between the committee and author during a review process.

 

The original manuscript should have the following structure: Introduction, Aims, Material and methods, Results, Discussion and Conclusions which cannot be a summary of the manuscript.

 

The volume of original papers – including figures and references – must not exceed 10 800 – 12 600 characters (6-7 pages of typescript or 1800 characters per 1 page).

 

ABSTRACT AND KEYWORDS

The abstract should contain 120-200 words. Abstracts of original, both clinical and experimental, papers should have the following structure: Aims, Material and methods, Results, Conclusions. Do not use abbreviations in the title or the abstract. The abstract is pasted or rewritten by the authors into the appropriate field in the application form in the editorial panel.

When using abbreviations, it is necessary to provide the full wording at the first time they are used.

 

Keywords (2-4) should be given according to MeSH (Medical Subject Headings Index Medicus catalogs). Keywords cannot be a repetition of the title of the manuscript.

 

Article’s language is English. The editors can help in finding the right person for translation or proofreading. Or you can use the resource Cambridge proofreading and editing (https://proofreading.org/ ) rely on.

 

At the beginning of the article, the history of the issue should be briefly outlined with reference to the sources of literature and the reasoning of the expediency and purpose of the research.

 

MATERIALS AND METHODS OF THE STUDY

The section “Materials and Methods of Research” should be presented with the description of methods and reagents, the conditions for conducting experiments in that way, so it could be possible to reproduce these experiments. It is sufficient to give a reference to well-known methods. The names of companies and manufacturers of reagents and used materials must be indicated. Type and number of test animals and methods of anesthesia and euthanasia must be indicated as well.

 

Experiments that conducted on living vertebrate must comply with the principles of the European Convention for the Protection of vertebrate animals used for experimental and other scientific purposes (Strasbourg, 1986), and the Law of Ukraine “On protection of animals from cruelty”. It is obligatory to refer to the extract from the meeting of the Ethics Committee.

 

If the experiments were conducted on humans it is necessary to give the evidence that persons were informed that the research met to the established standards of the Helsinki Declaration adopted in 1964 and revised 59th WMA General Assembly, Seoul, October 2008. Authors should note that the procedures were approved by the local Ethics Committee.

 

If studies were conducted on isolated tissues of animals or people, including cell culture, it is necessary to note the details of the methods by which these tissues were obtained, including the method of euthanasia or the method of anesthesia.

 

The digital data must be rounded up according to the established rules, taking into account the average experimental error. The probability of differences in indicators has to be proved by statistical analysis, referring to specific methods. It is prohibited to give the same results in tables and figures. It is also necessary to specify the program that was used for a statistical analysis of the results, the way of presentation of the results, the confidence interval or the distribution of values.

 

All designations and names of physical and chemical units of measurement should be given in the SI system.

 

RESULTS AND THEIR DISCUSSION

The direct replication of the table data should be avoided in this section. Discussion of the results should be limited to examining only the most important established facts, taking into account the preliminary data on the issue that was being studied. Most of the discussion should be devoted to the interpretation of the results.

 

CONCLUSIONS

The last section of the article needs to generalize the main concepts.

 

REFERENCES

References to sources of literature should be placed strictly in alphabetical order or ordered by citation and accordingly marked in the text of the manuscript. The numbers of quoted literature sources are given in square brackets. References to literary sources should be made in Vancouver style. There should be no more than 20 items.

 

Articles:

Meric F, Bernstam EV, Mirza NQ, Hunt KK, Ames FC, Ross M I, et al. Breast cancer on the world wide web: cross sectional survey of quality of information and popularity of websites. BMJ. 2002;324(7337):577-81.

Books:

Cooke A. A guide to finding quality information on the Internet: selection and evaluation strategies. 2nd ed. London: Library Association Publishing; 2001.

Two to six authors:

Feldman RS, Meyer JS, Quenzer LF. The American Psychiatric Press textbook of psychopharmacology. 2nd ed. Washington DC: American Psychiatric Association; 1998.

Seven or more authors/editors:

Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, et al., editors. Harrison's principles of internal medicine. 14th ed. New York: McGraw Hill; 1998.

Conference proceedings

Nelmes G. Container port automation. In: Corke P., Sukkarieh S. editors. Field and service robotics: results of the 5th international conference, 29-31 July 2005, Port Douglas. Berlin: Springer; 2006. p. 3-8.

Thesis or dissertation:

Croser C. Biochemical restriction of root extension under mechanical impedance. PhD thesis, University of Birmingham; 1997.

Website or webpage:

SukYin A. Catechol-O-Methyltransferase (COMT) gene and breast cancer. [online]. Human Genome Epidemiology Network, National Office of Public Health Genomics, Centers for Disease Control and Prevention: Atlanta GA; 2002 Jun [Accessed 8 September 2008]. Available from: http://www.cdc.gov/genomics/hugenet/factsheets/FS_COMT.htm

 

AUTHORSHIP CRITERIA AND AUTHORS’ CONTRIBUTION DETAILS

Submission to the Journal implies that all authors have read and agreed to its content, and they meet all the four criteria of the International Committee of Medical Journal Editors (http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html).

 

Authorship requires: 

   1. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
   2. Drafting the work or revising it critically for important intellectual content; AND
   3. Final approval of the version to be published; AND
   4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

 

ACKNOWLEDGEMENTS

Acknowledgments should be addressed to individuals who provided help but do not meet the ICMJE authorship criteria, and institutions that supported the article. It is strongly recommended to acknowledge the efforts of authors' editors and editing agencies in line with the Good Publication Practice (GPP3) guidelines (https://pubmed.ncbi.nlm.nih.gov/26259067/). Grant funding and any other financial support should be also stated.

 

CONFLICT OF INTEREST

All authors are requested to disclose any conflict of interest including any financial or personal relationship with other people or organizations within three years of beginning the submitted work that could inappropriately influence their study (http://www.icmje.org/conflicts-of-interest/).  

 

All authors are required to provide a Conflict of Interest Statement which is available at http://www.icmje.org/downloads/coi_disclosure.zip. This form should be uploaded with the revised manuscript upon submission. The forms should be uploaded as a single file.

 

The corresponding author must disclose any conflict of interest that any co-author may have.  If there is no conflict of interest, then the authors must state in the separate section: 'Conflict of Interest: The authors declare no conflict of interest'. (https://msu-journal.com/index.php/journal/conflict-of-interests)

 

SOURCES

Please provide the source of financial support if any.

 

AI IN WRITING PAPER

Authors should disclose information on the use of generative AI and technology through AI in the writing process by adding a statement at the end of their manuscript in the main manuscript file before the literature list.

 

The statement should be placed in a new section entitled "The use of artificial intelligence in the writing process" (the text of the following content):

"in preparing this work, the author (s) used [TOOL/SERVICE NAME] to [CAUSE]. After using this tool/service, the author (s) have reviewed and edited the content as necessary and are solely responsible for the content of the publication. "

 

Policy on the use of artificial intelligence in the preparation of illustrations for the article

The editors do not allow the use of AI to create or modify images in submitted manuscripts.

Adjustments to brightness, contrast or color balance are acceptable unless and until they hide and eliminate any information in the original. Image analysis tools or specialized software may be applied to the submitted manuscripts to identify probable irregularities in the image.

It is not acceptable (and refers to generative things) to create using AI graphs, diagrams, tables that do not knead figures and images.

 

Acceptable formats for individual elements of the article are as follows: 

   1. Content of the article – doc, docx, rtf, odt.
   2. Tables – doc, docx, rtf, odt
   3. Figures – JPG, GIF, TIF, PNG with a resolution of at least 300 dpi
   4. Captions for figures and tables.

 

Each manuscript is subject to verification in the anti-plagiarism system.

 

The contact details of scientific committee:

Ukraine

Andrii KOPCHAK – Doctor of Medical Sciences, Professor of the Department of Maxillofacial Surgery and Modern Dental Technologies, Educational and Scientific Institute of Dentistry, Bogomolets National Medical University, and Director of the Educational and Scientific Institute of Dentistry (Kyiv)

Tel.: +380674099037

kopchak@ua.fm

 

Slovak Republic

Andrej JENČA – Doctor honoris causa, Professor, Doctor of Medicine, Clinic of Dentistry and Maxillofacial Surgery, Faculty of Medicine, Pavol Jozef Šafárik University, and Specialized Hospital for Head and Neck Diseases Akademia Kosice (Kosice)

Tel.: +421905963250

andrej.jenca@upjs.sk